Background In patient-centered healthcare, the assessment and selection of treatment should be based on outcomes important to patients and the relative importance patients place on these outcomes. The evidence base on long-term treatment outcomes important to patients with bipolar disorder is inconclusive. Objective The aim of this study was to investigate the relative importance of patient-important outcomes in bipolar disorder, and to construct a holistic and logically sound shortlist of treatment outcomes relevant in the evaluation and selection of pharmacological treatment in bipolar disorder. Method Overall, 22 outpatients from southern and eastern Norway participated in four focus groups, and suggested outcomes important in treatment decisions. Quantitative, relative importance weights for treatment outcomes identified in literature reviews were elicited from each participant, employing a self-explicated approach (SEA). The method combined a ranking-and rating-stated preference exercise and resulted in a 0-100 SEA-score for each outcome.
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Background In patient-centered healthcare, the assessment and selection of treatment should be based on outcomes important to patients and the relative importance patients place on these outcomes. The evidence base on long-term treatment outcomes important to patients with bipolar disorder is inconclusive. Objective The aim of this study was to investigate the relative importance of patient-important outcomes in bipolar disorder, and to construct a holistic and logically sound shortlist of treatment outcomes relevant in the evaluation and selection of pharmacological treatment in bipolar disorder. Method Overall, 22 outpatients from southern and eastern Norway participated in four focus groups, and suggested outcomes important in treatment decisions. Quantitative, relative importance weights for treatment outcomes identified in literature reviews were elicited from each participant, employing a self-explicated approach (SEA). The method combined a ranking-and rating-stated preference exercise and resulted in a 0-100 SEA-score for each outcome.
Results Outcomes from the literature accommodated the outcomes suggested in the focus groups. Mean age in the sample was 42 years and 64 % were women. All patients completed the exercises with consistent results. The most important outcomes were severe depression (median SEA 95 [interquartile range 26]), severe mania (76 [40] ), quality of life (65 [53] ), work/school functioning (58 [48] ), and social functioning (54 [50] ). Avoiding severe mania was significantly more important to patients with bipolar disorder type I compared with patients with type II. Outcome scores correlated strongly (p \ 0.01) across the ranking and rating exercises. Based on the results, a simplified and consistent set of outcomes was constructed. Conclusions Patients' preferences for outcomes in the long-term treatment of bipolar disorder vary considerably. To advance patient-centered healthcare, we propose that researchers, clinical guideline producers, and patientclinician dyads integrate a taxonomy of patient-important outcomes, such as constructed in this study, when assessing treatment options.
Introduction
Bipolar disorder is a chronic, relapsing and often severe mood disorder, characterized by episodes of elevated and depressed mood. The lifetime prevalence of bipolar spectrum disorder has been estimated to be 2.4 % worldwide, with major country-specific variations [1] . Clinical practice guidelines and textbooks agree that pharmacological treatment is a cornerstone in long-term treatment of the condition and currently include recommendations for more than 40 different medications [2] [3] [4] [5] [6] [7] . The guidelines vary widely in terms of which and how many medications they present, thus offering partly inconsistent decision support.
An alternative approach to following recommendations is multi-criteria decision making, incorporating evidence on the anticipated outcomes of the alternatives, and patients' subjective outcome preferences [8] . Available medications in bipolar disorder diverge on outcomes such as manic and depressive relapse rates, as well as side effects [9] . Notably, evaluations of medicines are sensitive to the very choice of outcomes. In patient-centered medicine and shared decision making, medications should be assessed and selected based on outcomes important to the individual, and a trading off of the likely benefits and harms of the options [10] [11] [12] .
Outside of the clinical encounter, the value of evidence on patients' outcome preferences is acknowledged in drug development [13] , and increasingly in the development of clinical practice guidelines [14] .
Patients' preferences for treatment outcomes can be investigated in qualitative studies and in quantitative, stated preferences research. [15] [16] [17] . A recent systematic review conducted by our research group found that most studies of patients' preferences in psychopharmacological treatment have addressed only a small number of outcomes [18] . More often than not, the provenance of the outcomes in the studies was research and clinicians rather than direct input from patients, and outcome preferences of patients often differed from those of clinicians and other groups. In bipolar disorder, the evidence base is weak; only two studies measuring patient preferences for treatment outcomes in bipolar disorder were found [18] .
To be realistic, a stated preference method should be fast, discriminative and valid [19] . 'Self-explicated approaches' (SEAs) is a subgroup of stated preference methods that originated in product development and marketing and have become popular due to their ability to determine relative weights for a large number of outcomes with low cognitive burden, small expenses, and relatively undemanding design, analysis and interpretation compared with other methods [20, 21] . Research trials applying SEA methods have started to appear in healthcare, and early results indicate that the approaches might be feasible in patients with diverse conditions, including schizophrenia [22] [23] [24] .
Outcomes and outcome descriptions used in preference studies should represent the depth and complexity of information required in actual decisions [25] , and capture the aspects on which medications clearly and measurably differ, aspects that can be traded off against each other.
The first objective of this study was to investigate the relative importance of treatment outcomes to patients with bipolar disorder using the SEA, and to assess the discriminative value and feasibility of the method. The second objective was to construct a holistic taxonomy of patientimportant outcomes intended for use in trading off medication outcomes in stated preferences research, clinical practice guidelines, patient decision aids, and clinical practice.
Methods

Literature Reviews and Construction of Outcomes
In addition to conducting a review of psychopharmacological outcomes research [18] , we searched for outcomes in the Guidelines International Network (G-I-N) [26] and the National Guideline Clearinghouse (NGC) databases [27] for clinical practice guidelines in bipolar disorder published within the last 3 years, as well as the A-Z Inventory of Decision Aids from the Ottawa Hospital Research Institute (OHRI) [28] for patient decision aids in bipolar disorder. We also included major evidence-based textbooks. Two researchers (BL and EA) identified outcomes in chapters and paragraphs describing long-term treatment in bipolar disorder. Next, two researchers (ØE and KN) removed overlapping items and outcomes obviously lacking discerning value. Negatively framed outcomes were inverted and worded positively, ensuring that greater magnitude always indicated better performance. For simple and unambiguous outcomes, only short descriptions were constructed. The final list comprised 23 outcomes.
The outcomes, their descriptions and the SEA were piloted on four healthy subjects and amendments made to improve comprehension.
Patients and Settings
Subjects were recruited by an open invitation on the Facebook site of a Norwegian patient-association for bipolar disorder. In addition, psychiatrists working in a psychiatric hospital in Oslo invited eligible patients to participate. Outpatients aged between 18 and 65 years with bipolar disorder type I or II were included. Their diagnosis was confirmed either by the doctor referring the patient, or the patients themselves reported that they had been diagnosed by a physician. All patients had to currently be in a stable phase and regularly seeing a clinician. Patients with comorbid conditions and substance dependency were not excluded. The project was approved by the South-East Norway Regional Committee for Medical Research Ethics. All patients received written information about the study and signed an informed consent form before the sessions. Participants were free to withdraw at any time. Data were collected between 27 August and 21 October 2014. The subjects did not receive any allowances. All personal data were recoded into anonymous variables and stored on a password-protected computer.
Each session consisted of a focus-group discussion as well as an individual exercise consisting of one ranking and one rating task. All patients also replied to a questionnaire requesting information regarding age, sex, subtype of bipolar disorder, years since diagnosis, predominance of manic or depressive episodes, current medication, and current state of mood.
Focus Group
Four focus group discussions were conducted sequentially over 2 months. The interview format was structured group discussion, led by a psychiatrist who took the facilitator role. Sessions were partly scripted and accorded to recent focus-group recommendations [29] [30] [31] . After a warm-up exercise, participants were asked to imagine that they were going to assess and select long-term pharmacological treatment together with their clinician. The purpose of the focus group was to inform this decision problem by establishing important and relevant outcomes. Participants were asked to take into consideration what an ideal medication should do and what would distinguish a good treatment from a bad one, if costs were not an issue. A decision was made not to audio or video record the sessions. Instead, sessions were simultaneously transcribed by a second facilitator. The psychiatrist did not suggest outcomes or outcome descriptions but asked open, neutral, follow-up questions and encouraged participants to detail their suggestions. Towards the end of the session, the group reviewed the transcribed list of outcomes and was asked to consider whether any outcomes were missing. Before the individual exercise, two researchers (ØE and KN) compared the outcomes suggested in the focus group with the preconstructed set of outcomes with the intention of adding new items in case of major discrepancies.
Self-Explicated Approach
In the quantitative part of the session, each participant completed one ranking and one rating exercise individually. The facilitators introduced the SEA method and presented all predefined outcomes and outcome descriptions to participants (Table 1) . For weight gain, an attribute level of 5 kg was presented. Depressive and manic symptoms were classified as mild or severe. Each patient received 23 randomly sorted cards, each card containing one outcome.
Participants were first asked to rank the outcomes in order of importance and to remove the two cards with the least important outcomes. Each of the remaining 21 outcomes was then rated on a 5-point Likert scale: very important (5), important (4), moderately important (3), slightly important (2), and not important (1) . Each participant had written descriptions of the outcomes available at all times. Two researchers (ØE and KN) provided assistance on an as-needed basis during the exercise.
Statistical Methods
We calculated the product of the ranking (0-20) and rating (1-5) for all outcomes, for each participant, resulting in an individual SEA score ranging from 0 to 100. Outcomes excluded by individual patients were considered to be 'missing value' in the statistical SEA score analysis. All data were analyzed using SPSS version 22.0 (IBM Corporation, Armonk, NY, USA). Continuous data were expressed as mean (standard deviation [SD]) or median (interquartile range [IQR] ) and categorical data were presented as percentages. Correlations were analyzed and expressed using Pearson's correlation coefficient for normally distributed data and Spearman's rho for skewed data. Subgroups were compared using the unpaired t test or Mann-Whitney U test, and pairs of variables were compared using the paired samples t test or Wilcoxon matchedpairs signed rank test, as appropriate. Across methods, p values \0.05 were considered significant.
Construction of the Taxonomy
The ten outcomes with the largest importance weights given by the patients were selected as a seed set. A cumulative list of all outcomes transcribed during the focus groups was constructed by the researchers and mapped with the 23 outcomes identified in the literature reviews, resulting in an 'outcome tree' with four levels. We then merged the seed set and the complete set of outcomes, and restructured and simplified the resulting hierarchy in several iterative steps, until the taxonomy complied with the requirement of logical consistence, such as equal numbers 3 Results
Literature Reviews
Outcomes identified in the systematic review [18] were sorted according to a taxonomy modified from Opmeer et al. [32] . All clinical practice guidelines and textbooks addressed the prevention of new episodes, four of six referred to side effects and three mentioned hospitalization (see electronic supplementary material [ESM] Appendix 1). Table 1 includes the items constructed from the reviews that were presented to patients.
Study Participants
A total of 17 patients with bipolar disorder were recruited from a patient support group and 5 from the hospital. Of the 32 subjects who agreed to attend, 22 arrived at the sessions. The completion rate of both exercises was 100 %. The mean age was 42 years, 64 % were women, and the mean time since bipolar disorder diagnosis was 8 years. The age and sex distribution was comparable to other stated preference studies in bipolar disorder [33, 34] . Overall, 59 % reported a diagnosis of bipolar disorder type I, and 41 % reported bipolar disorder type II. The majority experienced depressive episodes more frequently than manic or mixed episodes. Ninety-one percent reported that their current mood was stable, 4.5 % reported mild mania, and 4.5 % reported mild depression. All participants reported taking medication for bipolar disorder at the time of the study, with the three most common agents being lithium, lamotrigine, and aripiprazole. Sample details are summarized in Table 2 .
Focus Group
Each focus group discussion lasted 45-75 min and included four to eight participants. A total of 141 medicationassociated outcomes were suggested. All outcomes could be categorized within the predefined 23 outcomes, and additional outcomes were therefore not added to the predefined set. The largest number of sub-outcomes was suggested for depression and mania, side effects, practical burden of treatment, social functioning, and fear of relapse. Four items in the initial set were not advocated in the focus groups: reduce burden to society, increase number of lifeyears, reduce risk of self-harm, and reduce risk to others. Compared with the cumulative set from all groups, the majority of outcomes had been mentioned in the first focus group. The number of new outcomes decreased with each succeeding session and in the fourth and last focus group no new outcomes were revealed.
Self-Explicated Approach
Patients completed both the ranking and rating tasks within 20-40 min, and reported no major problems. None of the patients provided ratings inconsistent with their rankings. Table 3 presents the ranking, rating, and SEA scores. The SEA scores were strongly correlated (p \ 0.01) with the corresponding ranking and rating scores (see ESM Appendix 3). The correlation between the rating and ranking scores was statistically significant (p \ 0.05) for 20 of the 23 variables.
The three most important outcomes, similarly ranked across the three methods, were avoid severe depression, avoid severe mania, and increase experienced quality of life. These outcomes were ranked among the three most important outcomes by 77, 60, and 36 %, respectively. No outcome was ranked among the top three by all patients. Based on the SEA scores, the other outcomes among the ten most important outcomes were, in decreasing order of importance, better functioning at school or work, better social functioning, avoid impaired cognition, reduce burden to relatives, avoid weight gain, avoid other long-term side effects, and avoid mild depression. Details are given in Fig. 1 and Table 3 .
The five outcomes with the lowest importance scores were, in decreasing order, increase number of life-years, reduce risk of self-harm, avoid practical burden of treatment, avoid short-term side effects, and reduce burden on society. The four predefined outcomes not suggested in any of the focus groups were ranked among the eight least important outcomes.
The mean (95 % confidence interval) difference in SEA score between neighboring pairs of outcomes was nonsignificant, except for one pair. Burden to society had an SEA score significantly lower than all other outcomes.
In subgroup analysis, the distribution of SEA scores for 22 of 23 outcomes was similar (p [ 0.05) across bipolar disorder type I (n = 13) versus type II (n = 9). A (Fig. 2) . No significant differences in SEA scores were observed in subgroup analyses for median time since diagnosis (more or less than 5 years), or sex.
Likert scales tend to produce ceiling effects, resulting in a high mean score towards the positive end of the scale, and a small SD. In this study, a strong ceiling effect was not observed. The mean (SD) Likert score for all 23 variables was 3.42 (0.76), with normally distributed scores ranging from 2.06 to 4.64.
Discussion
Principal Findings
The outcomes discussed in single research studies, guidelines, and clinical textbooks varied widely but the cumulative set of these outcomes accommodated the outcomes suggested by patients in the focus groups. All participants were able to complete the SEA, with consistent results. Severe symptoms, quality of life, and functioning were most important. Avoiding severe mania was significantly more important to patients with bipolar disorder type I compared with patients with type II. Avoiding burden to society was significantly less important than all other outcomes. SEA scores correlated strongly with ranking and rating scores. Patients' preferences varied considerably.
Results in Context
Our study confirms the position of severe depression and severe mania among the most important, and least desired, outcomes to patients with bipolar disorder. The prominence of weight gain among side effects was also confirmed in our study. In a choice-format web survey, Johnson et al. [33] found that weight gain, cognitive impairment, and severity of depression had the strongest impact on patients' stated adherence to hypothetical medications. In an earlier study [34] , patients provided their preferences for 55 hypothetical, bipolar-related health states. Patients assigned lower utilities to more severe symptoms compared with The correlation between the importance placed on severe mania and subtype of the disease is consistent with the diagnostic criteria; whereas the diagnosis of bipolar disorder type I requires at least one manic or mixed episode, in bipolar disorder type II the patient has never experienced a full manic episode [35] .
For bipolar disorder, we did not identify systematic reviews of treatment outcomes studied outside of stated preference research. In schizophrenia, a systematic review of non-traditional, patient-reported outcomes (PROs) reported that 75 outcomes were potentially useful [36] . The review sharply distinguishes between traditional outcomes reported from clinicians and outcomes reported directly from patients, which suggests that clinical outcomes are insufficient measures of the impact of health interventions. Patients have been found to place less value on 'textbook outcomes' such as symptoms and side effects, compared with global measures such as functioning and living a normal life [22] . This sharp distinction was not supported in the focus groups. Participants reported that clinical outcomes such as symptoms and side effects were important, alongside quality of life, functioning, and numerous consequences of the symptoms and side effects. From the perspective of patients, both traditional and non-traditional outcomes were important. Depending on definition, neither PROs nor patient-centered outcomes (PCOs) are necessarily patientimportant, in the sense that a high relative value of the outcome to patients has been documented in stated preference research.
Although the capabilities of patients with psychiatric disorders to provide stated preferences have been questioned, studies on patients with bipolar disorder have reported no or minor problems [33, 34] . Our results give
The ten most important outcomes further support to the view that patients with bipolar disorder are able to distinguish between, and trade-off, medication-related outcomes, and that an SEA can be feasible and acceptable in this group.
Self-Explicated Approach
Compared with conjoint analysis, the predictive validity and reliability of some SEAs has been found to be equal or even higher [37] . Various SEA methods exist. A fundamental distinction involves whether the procedure in the SEA incorporates a trade-off, for instance ranking tasks, or not. In non-trade-off methods such as rating scales, participants commonly assign too much importance to the outcomes. Trade-off methods might provide better discrimination [20] . In this study, in which respondents were asked to trade-off outcome importance weights for a high number of attributes, the results were normally distributed and no ceiling effect was observed.
Taxonomy of Patient-Relevant Outcomes
We propose the following taxonomy:
• Avoid burden of disease Descriptions are provided in ESM Appendix 2. In the taxonomy, the traditional outcomes symptoms and side effects are included in the broader concept of burden, to accommodate the complex 'outcome trees' depicted in the focus groups. For instance, 'manic symptoms' can result in consequences such as economic loss, increased burden to relatives, and reduced social functioning, which might result in long-lasting emotions and experiences, including 'shame'. All elements in this branch are included in the outcome 'avoid burden of acute manic episodes'. Thus, the structure reconciles clinical outcomes, such as symptoms, with outcomes that are interrelated but sometimes contrasted to these outcomes, such as quality of life and functioning.
The multi-attribute utility theory requires that the greater the range of an outcome, the greater the importance weight should be [38] . Hence, when the distance between Fig. 2 Boxplot of the difference in importance of severe mania rated by patients with bipolar disorder types I and II. The thick horizontal, black line represents the median value. Each box includes 50 % of the observations. The thin vertical line represents the range in observations, and the small circles represent outliers, defined as values more than 1.5 box lengths from the edge of the box. Between-group difference Mann-Whitney U test: p = 0.006 the best and worst value that can be expected from the available options on an outcome increases, and this increase is presented to the responder, the weight assigned to this outcome by the respondent should also increase. Current methods violate this range sensitivity principle to different degrees, resulting in possibly biased importance weights. In this study, precise ranges were not presented to participants because empirically based levels for all 23 outcomes were not available. The proposed taxonomy converts the challenge of establishing these levels, for all outcomes, into a realistic task.
The probabilities of acute episodes, as well as side effect tolerabilities, were recently examined in a systematic review and network meta-analysis of 17 pharmacological treatments, and were reported to differ significantly [9] .
Levels of bother, and burden of disease between episodes, is rarely addressed in the literature [18] , but might be considerable [39, 40] and are currently being investigated by our research team. In future studies, the range sensitivity of the outcome weights should be evaluated for all outcomes and the results used to further improve the taxonomy.
In the systematic review, the concepts of acute episodes did not include the total burden inflicted on patients as a result of the episodes. In line with the proposed taxonomy, researchers could consider including 'burden of acute episode' as a PRO in future clinical studies. A more immediate, possible use of the taxonomy presents itself to patients and clinicians who assess and select long-term medication together. The attributes of the outcomes, for instance the burden of an acute episode, can be consulted and discussed, ensuring that the patient considers the full impact an episode would have on her or his life.
Strengths and Weaknesses
To the best of our knowledge, this study is the first to apply an SEA to elicit preferences from patients with bipolar disorder. Not currently the norm in all stated preference studies, our set of outcomes was comprehensive, outcomes were elicited directly from patients, and variance was reported in detail [18] .
Our study has several weaknesses. Limited to a small convenience sample of stable outpatients, the results might not be generalizable to patients undergoing an acute episode or experiencing severely reduced functioning. However, the insight and judgment of patients in acute and inpatient phases is altered [41] , and preferences reported in this state might not be representative of the patient's valuations in a stable phase.
Because some outcomes presented for preference elicitation were not discussed in the focus groups, and the possibility that some viewpoints dominated in the discussion, there is a risk of starting point bias. The facilitators were not blinded to the predefined set of outcomes and this might have influenced the discussion.
The procedure allowed patients to discard outcomes that were not applicable or irrelevant. Because outcomes had to be included by the patient to be assigned a value, outcomes with less than 22 respondents might have been biased upwards. The number of patients including each outcome is provided in Table 3 . An alternative would have been assigning a zero value to the discarded outcomes; however, this would have potentially biased the SEA scores in the opposite direction.
Psychometric validation was not performed for the initial set of outcomes [22] . The instrument was constructed to be used once, different from the general purpose of psychometric tests, which is to construct instruments that can be used repeatedly. In general, psychometric testing is less relevant in stated preference research because the approaches are not grounded in classical testing theory but in random utility theory, which explicitly has a random component in the model. In addition, the methods can and should accommodate heterogeneity and different meaning of the attributes and levels, assigned by the respondents. Hence, an outcome such as 'quality of life' might have been interpreted uniquely by each respondent. This particular outcome warrants an additional comment. Stated preference methods differ from traditional, patient-reported, health-related quality of life methods. Specifically, the approaches elicit patients' relative or absolute valuations of attributes or components, such as states of health, rather than measuring this component or status [42] .
Notwithstanding this distinction, it can be objected that the interpretation by respondents of the 'quality of life' outcome might have included elements from other outcomes, such as social functioning and school/work functioning. The risk of overlap is a limitation of the original set of 23 outcomes, identified in the literature, and a main purpose of this study was to improve this set and construct a set of logically consistent outcomes. In the proposed taxonomy, this particular outcome has been replaced with the operationalization of this concept suggested by patients in the focus groups.
Meaning of the Study
Clinicians should be aware that patients' preferences in the long-term treatment of bipolar disorder vary, both in terms of which outcomes are relevant to the individual and the relative importance of the outcomes. To holistically address the decision, discussions of the effects of options on symptoms and side effects should include the impact these clinical outcomes have on the patient's functioning, quality of life, and emotions. Structured approaches to decision making used in research hold potential to inform the patient-doctor encounter and facilitate personalization of treatment, given that the methods are realistic and pragmatic [43] . This study indicates that an SEA is sufficiently simple to warrant exploration in clinical practice, for instance as a clinical tool. A patient decision aid for maintenance treatment in bipolar disorder has been constructed based on the six outcomes, and a study including patients and clinicians using the aid is currently being conducted. In a second study, the discerning value of the outcomes in the taxonomy is evaluated. The descriptions included in the taxonomy can be used to both construct sub-criteria and as elements in descriptions, in stated preference research.
From a societal perspective, the value of personalizing treatments to the individual's preferences or other personal attributes might be larger than identifying the best treatment based on averages [44, 45] .
To foster patient-centered medicine, discussions of longterm treatment in clinical practice guidelines and textbooks on bipolar disorder should focus on outcomes known, from research, to be relevant and important to patients. Available studies report patient-important outcomes to varying degrees, and to address these gaps in primary research should be encouraged [46] .
Conclusions
Our study indicates that stable patients with bipolar disorder can express preferences over outcomes using an SEA. Further research is needed to evaluate and compare the usefulness of these methods.
This work confirms that although preferences can vary widely, disease severity, quality of life, and social and vocational functioning are among the most important outcomes in psychopharmacological decisions. To optimize the patient-important benefits of medications, we suggest that researchers, clinical guideline developers, and clinicians evaluating medications in bipolar disorder consider a holistic, logically sound set of outcomes, transcending traditional outcomes.
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